FlowTriever catheters are nitinol disks that are designed to engage and disrupt clot mechanically.

This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada.

This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada.

This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada.

The FlowSaver Blood Return System is used with Inari Medical catheters and sheaths for autologous blood transfusion. See Instructions for Use for complete Indications for Use, contraindications, warnings, and precautions.

This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada.

Provides immediate access to Inari’s cutting-edge innovations to further improve patient outcomes; Locked-in pricing, regardless of devices used per case, enables favorable economics

Avoid using excessive force to advance or retract against resistance. If excessive resistance occurs, retrac and collapse the distal disks into the catheter and remove the device. Excessive force against resistance may result in damage to the device or vessel perforation.

Jan 6, 2025 · Under the terms of the definitive agreement, Stryker will commence a tender offer for all outstanding shares of common stock of Inari for $80 per share in cash. The boards of directors of both Stryker and Inari have unanimously approved the transaction.

This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada.